Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11046 | 946 | 42.4 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
332 | 17329 | COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CD21 | Author keyword | 23 | 38% | 5% | 48 |
2 | COMPLEMENT RECEPTOR 2 | Author keyword | 15 | 82% | 1% | 9 |
3 | CR2 | Author keyword | 14 | 53% | 2% | 18 |
4 | SOLUBLE CD21 | Author keyword | 13 | 80% | 1% | 8 |
5 | C3D | Author keyword | 10 | 37% | 2% | 23 |
6 | CR 2 | Author keyword | 9 | 67% | 1% | 8 |
7 | CD19 | Author keyword | 5 | 14% | 3% | 33 |
8 | COMPLEMENT RECEPTOR TYPE 2 | Author keyword | 5 | 63% | 1% | 5 |
9 | COMPLEMENT RECEPTORS | Author keyword | 4 | 20% | 2% | 19 |
10 | ASSOCIATION FREE ENERGY | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CD21 | 23 | 38% | 5% | 48 | Search CD21 | Search CD21 |
2 | COMPLEMENT RECEPTOR 2 | 15 | 82% | 1% | 9 | Search COMPLEMENT+RECEPTOR+2 | Search COMPLEMENT+RECEPTOR+2 |
3 | CR2 | 14 | 53% | 2% | 18 | Search CR2 | Search CR2 |
4 | SOLUBLE CD21 | 13 | 80% | 1% | 8 | Search SOLUBLE+CD21 | Search SOLUBLE+CD21 |
5 | C3D | 10 | 37% | 2% | 23 | Search C3D | Search C3D |
6 | CR 2 | 9 | 67% | 1% | 8 | Search CR+2 | Search CR+2 |
7 | CD19 | 5 | 14% | 3% | 33 | Search CD19 | Search CD19 |
8 | COMPLEMENT RECEPTOR TYPE 2 | 5 | 63% | 1% | 5 | Search COMPLEMENT+RECEPTOR+TYPE+2 | Search COMPLEMENT+RECEPTOR+TYPE+2 |
9 | COMPLEMENT RECEPTORS | 4 | 20% | 2% | 19 | Search COMPLEMENT+RECEPTORS | Search COMPLEMENT+RECEPTORS |
10 | ASSOCIATION FREE ENERGY | 4 | 75% | 0% | 3 | Search ASSOCIATION+FREE+ENERGY | Search ASSOCIATION+FREE+ENERGY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COMPLEMENT RECEPTOR TYPE 2 | 80 | 77% | 6% | 54 |
2 | T DEPENDENT ANTIGEN | 72 | 69% | 6% | 61 |
3 | CR 2 | 66 | 46% | 11% | 106 |
4 | C3D RECEPTOR | 64 | 62% | 7% | 66 |
5 | CD21 | 33 | 59% | 4% | 37 |
6 | CR 2 CD21 | 32 | 85% | 2% | 17 |
7 | CD19 CD21 COMPLEX | 27 | 60% | 3% | 30 |
8 | MOUSE COMPLEMENT RECEPTOR 1 | 24 | 82% | 1% | 14 |
9 | HAPTEN ANTIBODIES | 23 | 79% | 2% | 15 |
10 | SOLUBLE CD21 | 22 | 81% | 1% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The complement system in regulation of adaptive immunity | 2004 | 447 | 69 | 28% |
How antibodies use complement to regulate antibody responses | 2014 | 4 | 111 | 49% |
Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex | 2000 | 303 | 118 | 51% |
Antibody-mediated regulation of the immune response | 2006 | 63 | 71 | 59% |
Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex | 2005 | 56 | 53 | 64% |
Complement receptors CD21 and CD35 in humoral immunity | 2007 | 59 | 59 | 37% |
Regulation of Humoral Immunity by Complement | 2012 | 45 | 68 | 32% |
The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity | 1997 | 224 | 83 | 54% |
The role of complement in inflammation and adaptive immunity | 2001 | 116 | 37 | 57% |
CD19 differentially regulates BCR signalling through the recruitment of PI3K | 2014 | 1 | 30 | 80% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNOL IMM 19 | 2 | 67% | 0.2% | 2 |
2 | IMMUNOCHIM REGULAT CELLULAI INTERACT VIRALES | 1 | 50% | 0.2% | 2 |
3 | U354 | 1 | 33% | 0.3% | 3 |
4 | WELLCOME TRUST IMMUNOL UNIT | 1 | 19% | 0.5% | 5 |
5 | COPENHAGEN BLOOD TRANSFUS | 1 | 33% | 0.2% | 2 |
6 | NAT SCI IMMUNOL CELL BIOL | 1 | 23% | 0.3% | 3 |
7 | CARROLL | 1 | 50% | 0.1% | 1 |
8 | CEA G IMMUNOCHIM | 1 | 50% | 0.1% | 1 |
9 | DBMS ICH | 1 | 50% | 0.1% | 1 |
10 | EXPT MED INFECT DIS | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000222953 | COMPLEMENT RECEPTOR 1//COMPLEMENT RECEPTOR TYPE 1//CR1 |
2 | 0.0000157928 | ANTI R7V ANTIBODIES//C ADE//T CELL INFECTION |
3 | 0.0000147565 | COMPLEMENT SYNTHESIS//MRC TRANSPLANTAT TRANSPLANTAT IMMUNOL M//COMPLEMENTO |
4 | 0.0000109204 | CD59//CRRY//CD55 |
5 | 0.0000097614 | FOLLICULAR DENDRITIC CELLS//FOLLICULAR DENDRITIC CELL//RAT LYMPH NODE |
6 | 0.0000088008 | SURFACE IGM//IG ALPHA//MEMBRANE IMMUNOGLOBULIN |
7 | 0.0000085283 | BZLF1//BRLF1//VIRAL MOL TUMOR DIAGNOST UNIT |
8 | 0.0000083613 | SIGLEC//SIGLECS//SIGLEC 8 |
9 | 0.0000082956 | CD23//SOLUBLE CD23//LOW AFFINITY IGE RECEPTOR |
10 | 0.0000082571 | MEMORY B CELL//GERMINAL CENTER//B CELL MIGRATION |